Sreya Sanyal ’22 is right where she wants to be in the fight against cancer — at the cutting-edge of medical research. She’ll soon be using the breakthrough gene-editing technology CRISPR-Cas9, often described as “genetic scissors”, to study human disease as a post baccalaureate researcher with the National Institutes of Health (NIH) after graduation.
For Sanyal, whose parents met and graduated from medical school in India, her journey toward a career as a physician-scientist specializing in cancer biology has deep roots, beginning at the age of 10.